LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Getein Biotech Exhibits Advanced POCT Analyzers

By LabMedica International staff writers
Posted on 13 Nov 2023
Image: The Metis 6000 Modular System is being highlighted at MEDICA 2023 (Photo courtesy of Getein)
Image: The Metis 6000 Modular System is being highlighted at MEDICA 2023 (Photo courtesy of Getein)

Getein Biotech, Inc. (Nanjing, China) is exhibiting its range of advanced analyzers for point-of-care testing at MEDICA 2023.

At the MEDICA show, visitors to the Getein booth can experience its unique products and services first-hand that deliver efficient diagnostic and treatment solutions, helping healthcare professionals increase efficiency, reduce costs, and deliver a better patient experience. Getein is highlighting its Metis 6000 Modular System (Integrated Clinical Chemistry and Immunochemistry) that helps labs unlock efficiency and optimize space. The Metis 6000 Modular System comprises the MAGICL 6200 immunochemistry module with a throughput of up to 400 T/H, the CM-1000 clinical chemistry module with a throughput of up to 1000 T/H, and the SHC 200 pre-analytical module (optional) with a speed of 190 tubes/H.

Getein is also showcasing the Metis 600 Modular System (Integrated Immunofluorescence and Hematology) which provides a suitable solution for immunofluorescence and hematology testing in low-volume laboratories. The Metis 600 Modular System comprises the Getein 1200 immunofluorescence quantitative analyzer and the BHA-5100 automatic hematology analyzer. The combination of immunofluorescence and hematology methodologies allows for more comprehensive test items to be offered. Also on display at MEDICA 2023 is the BHA-5000 automatic 5-part differential hematology analyzer which uses laser-based flow cytometry to count white blood cells in blood samples. It also uses electrical impedance to count red blood cells and platelets, and colorimetry to measure the hemoglobin, and relevant parameters will be enumerated.

In addition, Getein is exhibiting the MAGICL 6000 chemiluminescence immunoassay analyzer designed for mid to high-workflow laboratories that require a one-step chemiluminescence solution. Alongside MAGICL 6000 was the Getein 1600 fully-automated immunofluorescence quantitative analyzer which combined with bar-coded, ready-to-use strip cassettes, delivers accurate testing results in minutes. The company is demonstrating the Getein 208 hand-held integrated system which is intended to detect and quantify specific chemical components in human blood serum, plasma, whole blood, capillary blood, and urine samples through dry chemistry and fluorescence immunoassay. Visitors to the company’s booth can learn about Getein’s POCT test menu which includes a wide range of reagent options, covering rapid testing for various diseases and health indicators.

Related Links:
Getein Biotech, Inc. 

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more